Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial (Q50438042)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 March 2015

edit

Language	Label	Description	Also known as
English	Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial	scientific article published on 12 March 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

title

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

main subject

phase III clinical trial

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

author

Christian Michel Zwaan

series ordinal

6

object named as

Christian Michel Zwaan

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

author name string

Hyoung Jin Kang

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

Susan Loftus

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

Arlene Taylor

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

Cara DiCristina

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

Stuart Green

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

publication date

12 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

published in

Lancet Oncology Commission

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

volume

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

page(s)

385-394

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

cites work

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey ranking of emetogenic control in children receiving chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute and delayed nausea and emesis control in pediatric oncology patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy side effects in pediatric oncology patients: Drugs, age, and sex as risk factors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Aprepitant: drug-drug interactions in perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of two rates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation of medicines for children

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970061-6

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1470-2045(15)70061-6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

PubMed publication ID

25770814

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25770814

retrieved

14 March 2018

reference URL

http://europepmc.org/abstract/MED/25770814

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50438042&oldid=2249336455"